US2017204041A1PendingUtilityA1

Processes for preparing (r)-1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1`-biphenyl]-2-yl)-2,2,2-trifluoroethanone

63
Assignee: KAROS PHARMACEUTICALS INCPriority: Mar 5, 2015Filed: Feb 13, 2017Published: Jul 20, 2017
Est. expiryMar 5, 2035(~8.6 yrs left)· nominal 20-yr term from priority
C07C 29/32C07C 259/10C07C 45/455C07C 49/80C07C 29/143C07B 2200/07
63
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to processes for the preparation of (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol, 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone, and intermediates thereof, which are useful in the preparation of inhibitors of TPH1 for the treatment of, for example, gastrointestinal, cardiovascular, pulmonary, inflammatory, metabolic, low bone mass diseases, serotonin syndrome, and cancer.

Claims

exact text as granted — not AI-modified
1 - 81 . (canceled) 
     
     
         82 . A compound which is a compound of Formula B: 
       
         
           
           
               
               
           
         
       
     
     
         83 . A compound which is a compound of Formula 1-3: 
       
         
           
           
               
               
           
         
       
       wherein X is I.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.